Recombinant multi-species DDX41 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX41 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of the DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene is a member of the DEAD box protein family and interacts with several spliceosomal proteins. In addition, the encoded protein may recognize the bacterial second messengers cyclic di-GMP and cyclic di-AMP, resulting in the induction of genes involved in the innate immune response. [provided by RefSeq, Jan 2017]
The Alternative Names of target: 2900024F02Rik,ABS,DDX41,DEAD box protein 41,DEAD box protein abstrakt homolog,Ddx41,MPLPF,Probable ATP-dependent RNA helicase DDX41

Target products collectionGo to DDX41 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9422-Ag-1/ GM-Tg-hg-IP9422-Ag-2 Human DDX41 protein Human
GM-Tg-rg-IP9422-Ag-1/ GM-Tg-rg-IP9422-Ag-2 Rat DDX41 protein Rat
GM-Tg-mg-IP9422-Ag-1/ GM-Tg-mg-IP9422-Ag-2 Mouse DDX41 protein Mouse
GM-Tg-cynog-IP9422-Ag-1/ GM-Tg-cynog-IP9422-Ag-2 Cynomolgus/Rhesus macaque DDX41 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9422-Ag-1/ GM-Tg-felg-IP9422-Ag-2 Feline DDX41 protein Feline
GM-Tg-cang-IP9422-Ag-1/ GM-Tg-cang-IP9422-Ag-2 Canine DDX41 protein Canine
GM-Tg-bovg-IP9422-Ag-1/ GM-Tg-bovg-IP9422-Ag-2 Bovine DDX41 protein Bovine
GM-Tg-equg-IP9422-Ag-1/ GM-Tg-equg-IP9422-Ag-2 Equine DDX41 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9422-Ag-1/ GM-Tg-hg-IP9422-Ag-2; GM-Tg-rg-IP9422-Ag-1/ GM-Tg-rg-IP9422-Ag-2;
GM-Tg-mg-IP9422-Ag-1/ GM-Tg-mg-IP9422-Ag-2; GM-Tg-cynog-IP9422-Ag-1/ GM-Tg-cynog-IP9422-Ag-2;
GM-Tg-felg-IP9422-Ag-1/ GM-Tg-felg-IP9422-Ag-2; GM-Tg-cang-IP9422-Ag-1/ GM-Tg-cang-IP9422-Ag-2;
GM-Tg-bovg-IP9422-Ag-1/ GM-Tg-bovg-IP9422-Ag-2; GM-Tg-equg-IP9422-Ag-1/ GM-Tg-equg-IP9422-Ag-2
Products Name DDX41 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DDX41
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX41 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.